To validate our platform, we first sequenced the genomes of 25 primary T-ALL cells isolated from an Mps1f/f; p53f/f; Lck-Cre+ lymphoma that we had previously assessed [15] by aCGH-analysis (T-ALL 1, aCGH data in Fig. 1a). The gene discussed is LCK; the disease is acute lymphoblastic leukemia.